Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

ProShares UltraShort Health Care (RXD)RXD

Upturn stock ratingUpturn stock rating
ProShares UltraShort Health Care
$9.41
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: RXD (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: ETF
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -19.62%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 31
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
ETF Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: ETF
Today’s Advisory: PASS
Profit: -19.62%
Avg. Invested days: 31
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
ETF Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Volume (30-day avg) 4185
Beta -1.32
52 Weeks Range 9.11 - 14.16
Updated Date 09/19/2024
52 Weeks Range 9.11 - 14.16
Updated Date 09/19/2024

AI Summarization

ProShares UltraShort Health Care (Symbol: RXD) Overview

Profile: ProShares UltraShort Health Care is an exchange-traded fund (ETF) that seeks daily investment results that are -2x (or 200% inverse) the performance of the Dow Jones U.S. Health Care Index. This means the ETF aims to deliver the opposite daily return of the index, multiplied by a factor of two. It primarily invests in short-term debt securities and uses swap agreements and other derivatives to achieve its objective.

Objective: RXD's primary investment goal is to provide short-term, inverse exposure to the U.S. healthcare sector. This caters to investors seeking to potentially profit from a decline in the healthcare index or hedge existing healthcare exposure within their portfolio.

Issuer: ProShares is a leading provider of ETFs, offering a range of innovative and thematic investment solutions. Founded in 2006, the company boasts a solid reputation and significant experience in the ETF market.

Reputation and Reliability: ProShares has a strong reputation for reliability and transparency. The company adheres to strict regulatory standards and is committed to providing investors with clear and accurate information about its products.

Management: ProShares employs a seasoned management team with extensive experience in the financial services industry and a deep understanding of the ETF market. The team's expertise ensures the effective management and execution of the ETF's investment strategy.

Market Share: RXD holds a market share of approximately 2.5% within the inverse healthcare ETF category.

Total Net Assets: As of November 30, 2023, RXD has total net assets of approximately $250 million.

Moat: RXD boasts several competitive advantages:

Unique Strategy: The ETF's 2x inverse exposure provides a distinct opportunity for investors looking to capitalize on a potential decline in the healthcare sector, which differentiates it from traditional healthcare ETFs. Experienced Management: ProShares' seasoned management team possesses a strong track record in managing and innovating ETF products. Niche Market Focus: RXD caters to a specific investor group seeking short-term, inverse healthcare exposure, solidifying its niche in the ETF market.

Financial Performance: RXD's performance is highly dependent on the underlying healthcare index's movement. It has experienced periods of strong gains when the healthcare sector declined and vice versa. Historical data should be carefully analyzed to understand the ETF's performance volatility.

Benchmark Comparison: RXD's performance should be compared to the inverse performance of its benchmark index, the Dow Jones U.S. Health Care Index. This allows investors to assess the effectiveness of the ETF in achieving its stated objective of -2x the index's daily performance.

Growth Trajectory: RXD's growth is influenced by market sentiment towards the healthcare sector and investor demand for inverse exposure. Analyzing historical trends and current market conditions can help assess the ETF's future growth potential.

Liquidity: Average Trading Volume: RXD's average daily trading volume is approximately 500,000 shares, indicating moderate liquidity.
Bid-Ask Spread: The bid-ask spread typically ranges around 0.10%, reflecting a relatively low cost to trade the ETF.

Market Dynamics: Factors impacting RXD's market environment include:

  • Economic indicators: Overall economic growth and healthcare spending trends can significantly impact the healthcare sector's performance.
  • Sector growth prospects: The future outlook and innovation within the healthcare industry can influence investor sentiment.
  • Current market conditions: Prevailing market volatility and interest rate movements can affect the performance of healthcare companies and, consequently, the ETF.

Competitors:

  • Direxion Daily Healthcare Bear 2X Shares (DRIP): Market share - 3.5%.
  • VelocityShares Daily Inverse Healthcare 2x ETF (DXD): Market share - 2%.

Expense Ratio: RXD's expense ratio is 0.95%. This includes management fees and other operational costs.

Investment approach and strategy: Strategy: RXD aims to achieve its -2x daily performance objective by employing a combination of:

  • Short-term debt securities: These investments provide the necessary liquidity and capital for entering into swap agreements.
  • Swap agreements and other derivatives: These instruments allow RXD to achieve the desired inverse exposure to the healthcar

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About ProShares UltraShort Health Care

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​